Rheumatology Quarterly

Successful Infliximab Treatment in Cogan Syndrome with Cardiac Complications [Rheumatol Q]
Rheumatol Q. 2024; 2(1): 0-0

Successful Infliximab Treatment in Cogan Syndrome with Cardiac Complications

Semih Gülle1, Merve Celik Guler1, Duygu Gürel3, Fatos Onen2
1Department of Internal Medicine, Dokuz Eylul University School of Medicine, Izmir, Turkey
2Division of Rheumatology, Department of Internal Medicine, Dokuz Eylul University School of Medicine, Izmir, Turkey
3Department of Pathology, Dokuz Eylul University School of Medicine, Izmir, Turkey

Cogan’s Syndrome (CS) is a rare chronic autoimmune vasculitis that can have significant systemic consequences and progress with progressive and inflammatory eye (interstitial keratitis, scleritis, episcleritis, uveitis) and audiovestibular (sensorineural hearing loss, vertigo, tinnitus) involvement. Vasculitis is seen in approximately 15% of patients with CS and may present as aortitis, large-vessel vasculitis (Takayasu-like), moderate arteritis, or other vasculitic syndromes. In this case report, we aimed to present the development of severe aortic and mitral valve insufficiency in a patient diagnosed with CS who was admitted to the hospital with episcleritis and sensorineural hearing loss.

Keywords: Cogan’s Syndrome, episcleritis, infliximab, giant arter vasculitis


Semih Gülle, Merve Celik Guler, Duygu Gürel, Fatos Onen. Successful Infliximab Treatment in Cogan Syndrome with Cardiac Complications. Rheumatol Q. 2024; 2(1): 0-0

Corresponding Author: Semih Gülle, Türkiye


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar